Oxymetholone is a synthetic hormone with anabolic and androgenic properties. It is used mainly in the treatment of anemias. Oxymetholone, marketed as Anadrol and Anapolon, is a synthetic anabolic steroid. Its primary clinical applications include treatment of osteoporosis and anaemia, as well as stimulating muscle growth in malnourished or underdeveloped patients. Oxymetholone is discontinued (DEA controlled substance). References: Nejati V, Zahmatkesh E, Babaei M. Protective Effects of Royal Jelly on Oxymetholone-Induced Liver Injury in Mice. Iran Biomed J. 2016 Sep;20(4):229-34. Epub 2016 May 14. PubMed PMID: 27178489. 2: Zahmatkesh E, Najafi G, Nejati V. Protective Effect of Royal Jelly on In Vitro Fertilization (IVF) in Male Mice Treated with Oxymetholone. Cell J. 2015 Fall;17(3):569-75. Epub 2015 Oct 7. PubMed PMID: 26464831; PubMed Central PMCID: PMC4601880. 3: Zhang QS, Benedetti E, Deater M, Schubert K, Major A, Pelz C, Impey S, Marquez-Loza L, Rathbun RK, Kato S, Bagby GC, Grompe M. Oxymetholone therapy of fanconi anemia suppresses osteopontin transcription and induces hematopoietic stem cell cycling. Stem Cell Reports. 2015 Jan 13;4(1):90-102. doi: 10.1016/j.stemcr.2014.10.014. Epub 2014 Nov 26. PubMed PMID: 25434823; PubMed Central PMCID: PMC4297866. 4: Afkhami A, Ghaedi H, Madrakian T, Nematollahi D, Mokhtari B. Electro-oxidation and voltammetric determination of oxymetholone in the presence of mestanolone using glassy carbon electrode modified with carbon nanotubes. Talanta. 2014 Apr;121-8. doi: 10.1016/j.talanta.2013.12.047. Epub 2013 Dec 30. PubMed PMID: 24607102. 5: Zahmatkesh E, Najafi G, Nejati V, Heidari R. Protective effect of royal jelly on the sperm parameters and testosterone level and lipid peroxidation in adult mice treated with oxymetholone. Avicenna J Phytomed. 2014 Jan;4(1):43-52. PubMed PMID: 25050300; PubMed Central PMCID: PMC4103725. 6: Madrakian T, Afkhami A, Rahimi M, Ahmadi M, Soleimani M. Preconcentration and spectrophotometric determination of oxymetholone in the presence of its main metabolite (mestanolone) using modified maghemite nanoparticles in urine sample. Talanta. 2013 Oct 15;115:468-73. doi: 10.1016/j.talanta.2013.05.056. Epub 2013 Jun 11. PubMed PMID: 24054620. 7: Khan NT, Bibi M, Yousuf S, Qureshi IH, Atta-Ur-Rahman N, Al-Majid AM, Mesaik MA, Khalid AS, Sattar SA, Atia-Tul-Wahab N, Choudhary MI. Synthesis of some potent immunomodulatory and anti-inflammatory metabolites by fungal transformation of anabolic steroid oxymetholone. Chem Cent J. 2012 Dec 10;6(1):153. doi: 10.1186/1752-153X-6-153. PubMed PMID: 23237028; PubMed Central PMCID: PMC3740782. 8: Sobolevsky T, Rodchenkov G. Mass spectrometric description of novel oxymetholone and desoxymethyltestosterone metabolites identified in human urine and their importance for doping control. Drug Test Anal. 2012 Sep;4(9):682-91. doi: 10.1002/dta.1407. Epub 2012 Sep 3. PubMed PMID: 22945829. 9: National Toxicology Program. Oxymetholone. Rep Carcinog. 2011;12:338-40. PubMed PMID: 21860526. 10: Aramwit P, Palapinyo S, Wiwatniwong S, Supasyndh O. The efficacy of oxymetholone in combination with erythropoietin on hematologic parameters and muscle mass in CAPD patients. Int J Clin Pharmacol Ther. 2010 Dec;48(12):803-13. PubMed PMID: 21084036. 1 Oxymetholone. Rep Carcinog. 2004;1III211-2. PubMed PMID: 21089941. 12: Hengge UR, Stocks K, Faulkner S, Wiehler H, Lorenz C, Jentzen W, Hengge D, Ringham G. Oxymetholone for the treatment of HIV-wasting: a double-blind, randomized, placebo-controlled phase III trial in eugonadal men and women. HIV Clin Trials. 2003 May-Jun;4(3):150-63. PubMed PMID: 12815555. 13: National Toxicology Program. NTP Toxicology and Carcinogenesis Studies of Oxymetholone (CAS NO. 434-07-1) in F344/N Rats and Toxicology Studies of Oxymetholone in B6C3F1 Mice (Gavage Studies). Natl Toxicol Program Tech Rep Ser. 1999 Aug;485:1-233. PubMed PMID: 12571678. 14: Bowers M. Oxymetholone. BETA. 1998 Jul:37-8. PubMed PMID: 11365560. 15: Karrow NA, McCay JA, Brown R, Musgrove D, Munson AE, White KL Jr. Oxymetholone modulates cell-mediated immunity in male B6C3F1 mice. Drug Chem Toxicol. 2000 Nov;23(4):621-44. PubMed PMID: 11071398. 16: Stoll RE, Holden HE, Barthel CH, Blanchard KT. Oxymetholone: III. Evaluation in the p53+/- transgenic mouse model. Toxicol Pathol. 1999 Sep-Oct;27(5):513-8. PubMed PMID: 10528630. 17: Holden HE, Studwell D, Majeska JB. Oxymetholone: I. Evaluation in a comprehensive battery of genetic toxicology and in vitro transformation assays. Toxicol Pathol. 1999 Sep-Oct;27(5):501-6. PubMed PMID: 10528628. 18: Clark AS, Harrold EV. Comparison of the effects of stanozolol, oxymetholone, and testosterone cypionate on the sexual behavior of castrated male rats. Behav Neurosci. 1997 Dec;111(6):1368-74. PubMed PMID: 9438805. 19: Clark AS, Blasberg ME, Brandling-Bennett EM. Stanozolol, oxymetholone, and testosterone cypionate effects on the rat estrous cycle. Physiol Behav. 1998 Jan;63(2):287-95. PubMed PMID: 9423971. 20: Hengge UR, Baumann M, Maleba R, Brockmeyer NH, Goos M. Oxymetholone promotes weight gain in patients with advanced human immunodeficiency virus (HIV-1) infection. Br J Nutr. 1996 Jan;75(1):129-38. PubMed PMID: 8785183.

纯度：≥98%

CAS：434-07-1